Cargando…
Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India
The main reason for the growth of mucormycosis in people with Coronavirus disease-2019 (COVID-19) is mainly produced by Rhizopus spp. The infective mechanisms and issues recognized in Rhizopus spp. are the cell wall, germination proteins, and enzymes assisted to iron sequestration, CotH protein, and...
Autores principales: | Ghosh, Deganta, Dey, Sagardeep, Chakraborty, Himanko, Mukherjee, Sneha, Halder, Ankita, Sarkar, Akash, Chakraborty, Pallab, Ghosh, Rajdeep, Sarkar, Joy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V. on behalf of INDIACLEN.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934183/ https://www.ncbi.nlm.nih.gov/pubmed/35342843 http://dx.doi.org/10.1016/j.cegh.2022.101013 |
Ejemplares similares
-
COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum
por: Dubey, Souvik, et al.
Publicado: (2021) -
Clinical profile of dermatitis neglecta with special emphasis on psychiatric comorbidities: A case series of 22 patients from Eastern India
por: Ghosh, Sudip K., et al.
Publicado: (2022) -
A comprehensive review of various categories of face masks resistant to Covid-19
por: Das, Sonali, et al.
Publicado: (2021) -
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
por: Kakoti, Bibhuti Bhusan, et al.
Publicado: (2022) -
Drug-induced diabetes and hepatoxicity in COVID-19 patients
por: Ghosh, Rajdeep, et al.
Publicado: (2022)